(MARYLAND) The United States is probing whether India's Ranbaxy Laboratories destroyed reports it was required to keep, falsified data and failed to meet quality control specifications in manufacturing its generic drugs.
Tuesday, July 15, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment